Literature DB >> 7940972

A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group.

D R Snydman1, B G Werner, N N Dougherty, J Griffith, R H Rohrer, R Freeman, R Jenkins, W D Lewis, E O'Rourke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7940972

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Introduction: disease overview and risk factors.

Authors: 
Journal:  P T       Date:  2010-03

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 3.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 4.  Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Markus J Barten; Fausto Baldanti; Alexander Staus; Christian M Hüber; Kyriaki Glynou; Andreas Zuckermann
Journal:  Life (Basel)       Date:  2022-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.